HTTP 200 OK
Allow: GET
Content-Type: application/json
Vary: Accept
{
"url": "https://lda.senate.gov/api/v1/filings/b8ce4e7d-76f5-4ba7-ad64-b41a8210e65c/?format=api",
"filing_uuid": "b8ce4e7d-76f5-4ba7-ad64-b41a8210e65c",
"filing_type": "Q1",
"filing_type_display": "1st Quarter - Report",
"filing_year": 2026,
"filing_period": "first_quarter",
"filing_period_display": "1st Quarter (Jan 1 - Mar 31)",
"filing_document_url": "https://lda.senate.gov/filings/public/filing/b8ce4e7d-76f5-4ba7-ad64-b41a8210e65c/print/",
"filing_document_content_type": "text/html",
"income": "10000.00",
"expenses": null,
"expenses_method": null,
"expenses_method_display": null,
"posted_by_name": "Joseph Robert Murray",
"dt_posted": "2026-06-11T09:45:22-04:00",
"termination_date": null,
"registrant_country": "United States of America",
"registrant_ppb_country": null,
"registrant_address_1": "601 Pennsylvania Avenue, NW",
"registrant_address_2": "Suite 900",
"registrant_different_address": false,
"registrant_city": "Washington",
"registrant_state": "DC",
"registrant_zip": "20004",
"registrant": {
"id": 401104348,
"url": "https://lda.senate.gov/api/v1/registrants/401104348/?format=api",
"house_registrant_id": null,
"name": "FIRST PRINCIPLES STRATEGIES, LLC",
"description": "Federal government affairs & strategic communications",
"address_1": "601 Pennsylvania Avenue, NW",
"address_2": "Suite 900",
"address_3": null,
"address_4": null,
"city": "Washington",
"state": "DC",
"state_display": "District of Columbia",
"zip": "20004",
"country": "US",
"country_display": "United States of America",
"ppb_country": "US",
"ppb_country_display": "United States of America",
"contact_name": "JOSEPH MURRAY",
"contact_telephone": "+1 703-307-1274",
"dt_updated": "2026-01-31T12:30:18.406819-05:00"
},
"client": {
"id": 53812,
"url": "https://lda.senate.gov/api/v1/clients/53812/?format=api",
"client_id": 53812,
"name": "OLD NORTH STRATEGIES, LLC ON BEHALF OF EXELA PHARMA SCIENCES, LLC",
"general_description": "Government Affairs Firm",
"client_government_entity": null,
"client_self_select": false,
"state": "NC",
"state_display": "North Carolina",
"country": "US",
"country_display": "United States of America",
"ppb_state": "NC",
"ppb_state_display": "North Carolina",
"ppb_country": "US",
"ppb_country_display": "United States of America",
"effective_date": "2023-01-01"
},
"lobbying_activities": [
{
"general_issue_code": "HCR",
"general_issue_code_display": "Health Issues",
"description": "Aluminum toxicity reduction policies in medicines",
"foreign_entity_issues": "",
"lobbyists": [
{
"lobbyist": {
"id": 69055,
"prefix": null,
"prefix_display": null,
"first_name": "JOSEPH",
"nickname": null,
"middle_name": "ROBERT",
"last_name": "MURRAY",
"suffix": null,
"suffix_display": null
},
"covered_position": "Senator Ron Johnson, Republican Study Committee, Rep. Mark Meadows",
"new": false
}
],
"government_entities": [
{
"id": 2,
"name": "HOUSE OF REPRESENTATIVES"
},
{
"id": 1,
"name": "SENATE"
}
]
},
{
"general_issue_code": "MAN",
"general_issue_code_display": "Manufacturing",
"description": "Advanced biotechnology manufacturing policies",
"foreign_entity_issues": "",
"lobbyists": [
{
"lobbyist": {
"id": 69055,
"prefix": null,
"prefix_display": null,
"first_name": "JOSEPH",
"nickname": null,
"middle_name": "ROBERT",
"last_name": "MURRAY",
"suffix": null,
"suffix_display": null
},
"covered_position": "Senator Ron Johnson, Republican Study Committee, Rep. Mark Meadows",
"new": false
}
],
"government_entities": [
{
"id": 2,
"name": "HOUSE OF REPRESENTATIVES"
},
{
"id": 1,
"name": "SENATE"
}
]
}
],
"conviction_disclosures": [],
"foreign_entities": [],
"affiliated_organizations": []
}